Parradee Kietsirikul
- Johnson & Johnson (NYSE:JNJ) is in talks to purchase cardiovascular-focused medical technology company Shockwave Medical (NASDAQ:SWAV).
- The Wall Street Journal reported that a deal could come in weeks, though it could be scuttled if another bidder expresses interest.
- Shockwave (SWAV) has a market cap of ~$11B. It is up ~12% in Tuesday afternoon trading on the chatter.
- In its Q4 2023 financial results released last month, the company beat on both lines.
- In late February, Seeking Alpha analyst Myriam Alvarez issued a strong buy rating for Shockwave (SWAV) and explained why it stands out in the medical device sector.